I agree with you.It has a lot more in its favour as a strong spec buy than others. With a bit of time i'm sure the market will pick up on this one.
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game